Fleur M. Ferguson, PhD
Assistant Professor Skaggs School of Pharmacy and Pharmaceutical Sciences, Dept of Biochemistry and Molecular Biophysics
- Research
- Academics
- Publications
Research
Research Summary
Research in the Ferguson laboratory applies chemical synthesis, biochemistry, mass spectrometry and cell biology towards the goal of developing new therapeutic strategies in cancer and neurodegenerative disorders. Our research seeks to enable dissection of the cellular signaling networks underlying disease through development of selective tool compounds that act via inhibition, targeted degradation, proximity mediated-pharmacology, or alterations of posttranslational modifications. We cultivate a multidisciplinary and highly collaborative approach to science to tackle fundamental questions in disease biology and drug discovery.
Key Contributions
- Development of a chemoproteomic map of the degradable kinome, including chemical leads for > 200 kinases to accelerate degrader discovery efforts, large-scale chemical exploration of key variables for targeted protein degradation and new insights into fundamentals of ubiquitin-mediated protein turnover.
- Development of selective targeted protein degraders of aberrant tau proteins.
- Development of chemical probes for understudied kinases (DCLK1, CDK14-18), to interrogate their biological function and role in cancer.
Potential Collaborative Programs
- Expertise in medicinal chemistry, development of selective chemical probes and targeted protein degraders.
- Expertise in fragment-based ligand discovery and screening, biophysics.
Academics
Academic Achievements
Education: M.Sc Chemistry (2010), Imperial College London; Ph.D Chemistry (2014), University of Cambridge; Postdoctoral studies (2015-2020), Dana-Farber Cancer Institute & Harvard Medical School.
Awards and Honors: Novartis Early Career Award in Organic Chemistry (2026), Pershing Square Cancer Research Alliance Sohn Cancer Prize (2026), American Chemical Society Division of Medicinal Chemistry, Philip S. Portoghese Early Career Award (2026), Royal Society of Chemistry Medicinal Chemistry Emerging Investigator Lectureship (2026), Sloan Research Scholar in Chemistry (2026), International Chemical Biology Society Young Chemical Biologist Award (2025), Pew Biomedical Research Scholar (2025), American Chemical Society San Diego Outstanding Committee Chair Award (2024), NSF CAREER (2024), NIH Director’s New Innovator Award (2022), W. M. Keck Foundation Research Grant (2022), PhRMA Foundation New Investigator Award in Drug Discovery (2021), Larry L. Hillblom New Investigator Award in Aging (2021), Alzheimer’s Association New Investigator Award (2021), William A. Lee Chancellor's Endowed Junior Faculty Fellowship (2021), DFCI Department of Cancer Biology Retreat Poster Award (2019), Royal Society of Chemistry, Chemistry-Biology Interface Division Travel Award (2014), Cambridge Philosophical Society Travel Award (2012, 2014), Emmanuel College Graduate Fund Travel and Research Award (2012), Biotechnology and Biological Sciences Research Council PhD Studentship (2010-2014), Imperial College London Chemistry Award for Outstanding Overall Performance (2010)
Teaching
- Chemical Biology (CHEM116, CHEM216)
- Organic Chemistry (CHEM 40B)
- Principles of Pharmaceutical Sciences and Drug Development (SPPS 263A)
- Pharmaceutical Chemistry (SPPS 221)
Publications
Selected Publications
- G. E. Gadbois, A. P. Plonski, G. T. Debelouchina, F. M. Ferguson. A Degron Decoy System Co-optsPathological Seeding to Enable Clearance of Multimeric α-Synuclein. bioRxiv, 2026. DOI:10.64898/2026.02.23.706428. (in revision, Nature Communications)
- S. Kumar*, J. Jiang*, M. S. Donald Paladino, A. Gutierrez, A. J. Federation, F. Szulzewsky, E. C.Holland, F. M. Ferguson#, B. Nabet#. Development of PROTACs for targeted degradation of oncogenic TRK fusions. RSC Chemical Biology, 2026, DOI: 10.1039/d6cb00008h. • Emerging Investigators Special Issue. • Featured on Inside Front Cover
- M. Ma*, Y. Wang*, J. Koeckenberger, A. Tao, E. Mumby, J.Jiang, S. S. V. M. Madaka, J. G. English,F. M. Ferguson. The APEXTAC System for Ligand-guided Proximity Labeling. 2025, ChemBioChem2025, DOI: 10.1002/cbic.202500602
- N. L. Tran*, J. Jiang*, M. Ma, G. Gadbois, K. C. M. Gulay, A. Verano, H. Zhou, C.-T. Huang, D.A. Scott, A. G. Bang, H. Tiriac, A. M. Lowy, E. S. Wang#, F.M. Ferguson#. ZBTB11 Depletion TargetsMetabolic Vulnerabilities in K-Ras-inhibitor Resistant PDAC. Nature Chemical Biology 2025, DOI:10.1038/s41589-025-01978-1. • Highlighted in News and Views: AbuHammed & Slabiki, 2026.
- J. Jiang*, N. L. Tran*, E. Svendsen, E. S. Wang#, F. M. Ferguson#. Synthesis and structure-activityrelationships of CRBN-recruiting ZBTB11 molecular glue degraders. Journal of Medicinal Chemistry 2025, DOI: 10.1021/acs.jmedchem.5c01352
- G. A. Leconte*, G. E. Gadbois*, Y. Sepulveda, A. Schwarz, E. Chang, R. Suhandynata, J. Momper,F.M. Ferguson. A Lipid Prodrug Strategy Enhances Targeted Protein Degrader CNSPharmacokinetics. Journal of Medicinal Chemistry 2025, DOI: 10.1021/ acs.jmedchem.5c00866
- A.T. Fan*, G.E. Gadbois*, H-T. Huang, C. Chaudhry, J. Jiang, L. Sigua, E.R. Smith, S. Wu, G.J. Poirier,K. Dunne-Dombrink, P. Goyal, A.J. Tao, W. Sellers, E.S. Fischer, K. A. Donovan, F.M. Ferguson. AKinetic Scout Approach Accelerates Targeted Protein Degrader Development., Angewandte ChemieInternational Edition 2025. DOI:10.1002/anie.202417272. • Designated ‘Hot Article’.
- A.J. Tao*, J. Jiang*, G.E. Gadbois, P. Goyal, B.T. Boyle, E.J. Mumby, S.A. Myers, J.G. English#, F.M.Ferguson#, A Biotin Targeting Chimera (BioTAC) System to Map Small Molecule Interactomes insitu. Nature Communications 2023. DOI: 10.1038/s41467-023-43507-5. • Top 25 most read articlesin chemistry and materials sciences, 2023.
- S.S. Ryu*, G. E. Gadbois*, A. J. Tao*, B. J. Fram, J. Jiang, B. T. Boyle, K. A. Donovan, N. M. Krupnick,B. C. Berry, D. Bhunia, I. Shin, E. S. Fischer, N. S. Gray#, T. Sim#, F. M. Ferguson#. Synthesis andstructure-activity relationships of targeted protein degraders for the understudied kinase NEK9. Current Research in Chemical Biology 2021, DOI: 10.1016/j.crchbi.2021.100008.
- M. C. Silva, G. Nandi, K. A. Donovan, Q. Cai, B. Berry, R. P. Nowak, E. S. Fischer, N. S. Gray, F. M.Ferguson#, S. J. Haggarty#. Discovery and optimization of aberrant tau targeted protein degradersenabled by patient iPSC-derived neuronal tauopathy models. Frontiers in Cellular Neuroscience 2022, DOI: 10.3389/fncel.2022.801179.
* Denotes co-first authors. # Denotes co-corresponding authors.
Stay Connected
Follow us on social media
Subscribe to our newsletter
Subscribe Now